BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 16020971)

  • 1. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
    Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G
    Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway.
    Delhanty PJ; van Koetsveld PM; Gauna C; van de Zande B; Vitale G; Hofland LJ; van der Lely AJ
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E302-9. PubMed ID: 17405826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland.
    Ueberberg B; Unger N; Sheu SY; Walz MK; Schmid KW; Saeger W; Mann K; Petersenn S
    Horm Metab Res; 2008 Mar; 40(3):181-8. PubMed ID: 18246525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone secretagogue receptor subtypes 1a and 1b are expressed in the human adrenal cortex.
    Carraro G; Albertin G; Abudukerimu A; Aragona F; Nussdorfer GG
    Int J Mol Med; 2004 Feb; 13(2):295-8. PubMed ID: 14719137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a.
    Delhanty PJ; van der Eerden BC; van der Velde M; Gauna C; Pols HA; Jahr H; Chiba H; van der Lely AJ; van Leeuwen JP
    J Endocrinol; 2006 Jan; 188(1):37-47. PubMed ID: 16394173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines.
    Cassoni P; Ghé C; Marrocco T; Tarabra E; Allia E; Catapano F; Deghenghi R; Ghigo E; Papotti M; Muccioli G
    Eur J Endocrinol; 2004 Feb; 150(2):173-84. PubMed ID: 14763915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental, stage-specific, and hormonally regulated expression of growth hormone secretagogue receptor messenger RNA in rat testis.
    Barreiro ML; Suominen JS; Gaytán F; Pinilla L; Chopin LK; Casanueva FF; Diéguez C; Aguilar E; Toppari J; Tena-Sempere M
    Biol Reprod; 2003 May; 68(5):1631-40. PubMed ID: 12606422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related changes in gene expression of the growth hormone secretagogue and growth hormone-releasing hormone receptors in Holstein-Friesian cattle.
    Komatsu M; Kojima M; Okamura H; Nishio M; Kaneda M; Kojima T; Takeda H; Malau-Aduli AE; Takahashi H
    Domest Anim Endocrinol; 2012 Feb; 42(2):83-93. PubMed ID: 22056236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin enhances the growth of cultured human adrenal zona glomerulosa cells by exerting MAPK-mediated proliferogenic and antiapoptotic effects.
    Mazzocchi G; Neri G; Rucinski M; Rebuffat P; Spinazzi R; Malendowicz LK; Nussdorfer GG
    Peptides; 2004 Aug; 25(8):1269-77. PubMed ID: 15350694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors.
    Gaytan F; Barreiro ML; Caminos JE; Chopin LK; Herington AC; Morales C; Pinilla L; Paniagua R; Nistal M; Casanueva FF; Aguilar E; Diéguez C; Tena-Sempere M
    J Clin Endocrinol Metab; 2004 Jan; 89(1):400-9. PubMed ID: 14715878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of prepro-ghrelin and related receptor genes in the rat adrenal gland and evidences that ghrelin exerts a potent stimulating effect on corticosterone secretion by cultured rat adrenocortical cells.
    Rucinski M; Ziolkowska A; Tyczewska M; Malendowicz LK
    Peptides; 2009 Aug; 30(8):1448-55. PubMed ID: 19416745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
    Muccioli G; Baragli A; Granata R; Papotti M; Ghigo E
    Neuroendocrinology; 2007; 86(3):147-64. PubMed ID: 17622734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a).
    Carreira MC; Camiña JP; Díaz-Rodríguez E; Alvear-Perez R; Llorens-Cortes C; Casanueva FF
    J Endocrinol; 2006 Oct; 191(1):147-57. PubMed ID: 17065398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors.
    Gaytan F; Morales C; Barreiro ML; Jeffery P; Chopin LK; Herington AC; Casanueva FF; Aguilar E; Dieguez C; Tena-Sempere M
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1798-804. PubMed ID: 15585554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin, an endogenous ligand for the growth hormone-secretagogue receptor, is expressed in the human adrenal cortex.
    Tortorella C; Macchi C; Spinazzi R; Malendowicz LK; Trejter M; Nussdorfer GG
    Int J Mol Med; 2003 Aug; 12(2):213-7. PubMed ID: 12851720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.
    Muccioli G; Pons N; Ghè C; Catapano F; Granata R; Ghigo E
    Eur J Pharmacol; 2004 Sep; 498(1-3):27-35. PubMed ID: 15363972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
    De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
    Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.
    Gnanapavan S; Kola B; Bustin SA; Morris DG; McGee P; Fairclough P; Bhattacharya S; Carpenter R; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2988. PubMed ID: 12050285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.